Csenge Advisory Group’s Boston Scientific BSX Stock Holding History

Csenge Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$228K	Buy	+5,229	New	+$242K	0.01%	678
2025 Q3	–	Sell	-2,101	Closed	-$221K	–	694
2025 Q2	$221K	Sell	2,101 -646	-24%	-$65.4K	0.01%	637
2025 Q1	$261K	Sell	2,747 -322	-10%	-$32.4K	0.01%	567
2024 Q4	$274K	Sell	3,069 -1,238	-29%	-$109K	0.01%	573
2024 Q3	$375K	Buy	4,307 +435	+11%	+$34.3K	0.02%	497
2024 Q2	$298K	Buy	3,872 +278	+8%	+$20.3K	0.02%	525
2024 Q1	$246K	Buy	+3,594	New	+$231K	0.01%	606
2018 Q4	–	Sell	-188	Closed	-$6K	–	371
2018 Q3	$6K	Buy	+188	New	+$6.57K	﹤0.01%	581

Other funds holding BSX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Csenge Advisory Group's BSX Position: Q3 2026 in Review

Csenge Advisory Group opened a new position in Boston Scientific (BSX) in Q3 2026: 5,229 shares worth $228K. The stake represents 0.01% of the portfolio and ranks #678 among its holdings. This is a return to the name: Csenge Advisory Group previously reported a position in BSX as recently as Q2 2025.

Csenge Advisory Group first reported a position in BSX in Q3 2018 and has held it in 8 quarters since. The position peaked at $375K in Q3 2024. 844 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Csenge Advisory Group held 5,229 shares of Boston Scientific worth $228K as of Q3 2026.
Boston Scientific was a new Csenge Advisory Group position in Q3 2026.
Boston Scientific made up 0.01% of Csenge Advisory Group's portfolio in Q3 2026, its #678 holding.
Csenge Advisory Group first reported a position in Boston Scientific in Q3 2018 and has held it in 8 quarters since.
Csenge Advisory Group's Boston Scientific position peaked at $375K in Q3 2024.
844 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Csenge Advisory Group's 13F filing for Q3 2026, filed 4 Nov 2026.